Technical Amendment to the Regulation Regarding Amendments to Applications

Published

Nov 4, 2026

Effective

Nov 4, 2026

Citation

91 FR 69500

Docket

Docket No. DEA-1303

Agencies

DEPARTMENT OF JUSTICE, Drug Enforcement Administration

Final rule; technical amendment.

Summary

The Department of Justice’s Drug Enforcement Administration (DEA) has issued a technical amendment to its existing regulation on applications for drug‑related registrations. The amendment simply clarifies that the same rules governing changes to, or withdrawal of, an initial registration application also apply when a company or individual files a renewal application. No substantive policy or procedural changes are introduced; the rule is purely an editorial update to ensure consistent wording across all types of registration filings. The rule affects any person or entity that submits a registration application to the DEA—whether for a new registration or for renewing an existing one—such as manufacturers, distributors, pharmacies, and research laboratories that handle controlled substances. Because the amendment is purely technical, it does not impose new requirements beyond the existing ones. The amendment was published in the Federal Register on November 4, 2026 (91 FR 69500) and is effective the same day, November 4, 2026. As a final rule, there is no comment period, and the clarification is now in force. Stakeholders should continue to follow the existing application procedures, now expressly confirmed to cover renewal filings as well.

AI-generated summary — verify against the Federal Register text.

Topics

Share